Skip to main content

Month: February 2024

Epazz Holdings: ZenaDrone Gains Major Traction to the US Air Force SBIR Award Demonstrations

Following a successful collaboration with the US Air Force in SBIR Award Phase 1, ZenaDrone has gained significant traction in acquiring additional contracts valued at $1.2 million CHICAGO, IL, Feb. 07, 2024 (GLOBE NEWSWIRE) — via NewMediaWire – Epazz, Inc. (OTC Pink: EPAZ), a mission-critical provider of drone technology, blockchain mobile apps, and cloud-based business software solutions, has announced today that its holdings company ZenaDrone, Inc., a company known for its multi-patented drone technology, is excited to announce flight demonstrations of ZenaDrone 1000 with several units of the US Air Force. The flight demonstrations are instrumental for ZenaDrone to obtain memorandums of understanding (MOUs), which are essential to winning up to $1.2 million for the SBIR Phase 2 contract. Following a successful collaboration...

Continue reading

CVR Partners to Release Fourth Quarter and Full-Year 2023 Earnings Results

SUGAR LAND, Texas, Feb. 07, 2024 (GLOBE NEWSWIRE) —  CVR Partners, LP (NYSE: UAN), a manufacturer of ammonia and urea ammonium nitrate (UAN) solution fertilizer products, plans to release its fourth quarter and full-year 2023 earnings results on Tuesday, February 20, after the close of trading on the New York Stock Exchange. The Partnership also will host a teleconference call on Wednesday, February 21, at 11 a.m. Eastern to discuss these results. This call, which will contain forward-looking information, will be webcast live and can be accessed on the Investor Relations section of CVR Partners’ website at www.CVRPartners.com. For investors or analysts who want to participate during the call, the dial-in number is (877) 407-8029. The webcast will be archived and available for 14 days at https://edge.media-server.com/mmc/p/ep887atw/....

Continue reading

KP Tissue to Release its Financial Results and those of Kruger Products Inc. for the Fourth Quarter of 2023

MISSISSAUGA, Ontario, Feb. 07, 2024 (GLOBE NEWSWIRE) — KP Tissue Inc. (“KPT”) (TSX:KPT), which holds an interest in Kruger Products Inc. will release the financial results for KPT and Kruger Products Inc. for the fourth quarter of 2023 on Thursday, March 7, 2024 before the market opens. KPT will hold its conference call the same day at 8:30 a.m. Eastern Time. Details of the Conference Call Via telephone: 1-888-664-6383 or 416-764-8650Via the internet at: www.kptissueinc.com Presentation material referenced during the conference call will be available at www.kptissueinc.com Conference Call Rebroadcast A rebroadcast of the conference call will be available until midnight, March 14, 2024 by dialing 1-888-390-0541 or 416-764-8677 and entering passcode 631417. The replay of the webcast will remain available on the web site until midnight,...

Continue reading

CVR Energy to Release Fourth Quarter and Full-Year 2023 Earnings Results

SUGAR LAND, Texas, Feb. 07, 2024 (GLOBE NEWSWIRE) — CVR Energy, Inc. (NYSE: CVI) plans to release its fourth quarter and full-year 2023 earnings results on Tuesday, February 20, after the close of trading on the New York Stock Exchange. The Company also will host a teleconference call on Wednesday, February 21, at 1 p.m. Eastern to discuss these results. This call, which will contain forward-looking information, will be webcast live and can be accessed on the Investor Relations section of CVR Energy’s website at www.CVREnergy.com. For investors or analysts who want to participate during the call, the dial-in number is (877) 407-8291. The webcast will be archived and available for 14 days at https://edge.media-server.com/mmc/p/db86jutg/. A repeat of the call also can be accessed for 14 days by dialing (877) 660-6853, conference...

Continue reading

iPower Schedules Fiscal Second Quarter 2024 Conference Call for February 14, 2024 at 4:30 p.m. ET

DUARTE, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) — iPower Inc. (Nasdaq: IPW) (“iPower” or the “Company”), a tech and data-driven online retailer and supplier of consumer home and garden products, as well as a provider of value-added ecommerce services, will host a conference call on Wednesday, February 14, 2024 at 4:30 p.m. Eastern time to discuss its financial results for the fiscal second quarter ended December 31, 2023. The Company’s results will be reported in a press release prior to the call. iPower management will host the conference call, followed by a question-and-answer period. Date: Wednesday, February 14, 2024Time: 4:30 p.m. Eastern timeDial-in registration link: hereLive webcast registration link: here Please dial into the conference call 5-10 minutes prior to the start time. If you have any difficulty connecting with...

Continue reading

LiveOne (Nasdaq: LVO) Appoints Aaron Sullivan as CFO

LOS ANGELES, CA, Feb. 07, 2024 (GLOBE NEWSWIRE) — via NewMediaWire – LiveOne (Nasdaq: LVO), an award-winning, creator-first music, entertainment, and technology platform, announced today the appointment of Aaron Sullivan as CFO. Mr. Sullivan previously served as Vice President, Corporate Controller, and as LiveOne’s Interim Chief Financial Officer. Robert Ellin, Chairman and CEO of LiveOne, commented, “Aaron has been with LiveOne since March 2019 and for the past two years, he has done an incredible job serving as the interim CFO. During this period, it became obvious to everyone Aaron brings the right talent and experiences and has been an instrumental leader strengthening our financial and operational management.” About LiveOne, Inc. LiveOne, Inc. is an award-winning, creator-first, music, entertainment, and technology...

Continue reading

CervoMed Announces Appointment of Industry Leader Joshua Boger, Ph.D., as Chair of the Board

Dr. Boger is the founder, and retired CEO and Board Chair, of Vertex Pharmaceuticals CervoMed on track to complete enrollment in 1H 2024 in its RewinD-LB Phase 2b clinical trial evaluating neflamapimod in patients with dementia with Lewy bodies; topline data expected in 2H 2024 BOSTON, Feb. 07, 2024 (GLOBE NEWSWIRE) — CervoMed Inc. (NASDAQ: CRVO), a clinical-stage company developing treatments for degenerative diseases of the brain, today announced the appointment of Joshua Boger, Ph.D., to its Board of Directors (Board) and as Chair of the Board. Dr. Boger is an innovative scientist and highly successful business executive who brings extensive drug development and biopharmaceutical company leadership experience to CervoMed as it progresses toward an important inflection point. Topline data from the RewinD-LB Phase 2b clinical...

Continue reading

MasterCraft Boat Holdings, Inc. Reports Results for Fiscal 2024 Second Quarter

VONORE, Tenn., Feb. 07, 2024 (GLOBE NEWSWIRE) — MasterCraft Boat Holdings, Inc. (NASDAQ: MCFT) today announced financial results for its fiscal 2024 second quarter ended December 31, 2023. The highlights, commentary, and results provided herein relate to our continuing operations. Highlights:Net sales for the second quarter was $99.5 million, down 37.5% from the prior-year period Net income from continuing operations was $5.9 million, or $0.35 per diluted share Diluted Adjusted Net Income per share, a non-GAAP measure, was $0.37, down 69.2% from the prior-year period Adjusted EBITDA, a non-GAAP measure, was $9.8 million, down 67.2% from the prior-year period Share repurchases of $4.4 million during the quarter Ended the quarter with cash and investments of $108.8 millionFred Brightbill, Chief Executive Officer and Chairman,...

Continue reading

Baltic Horizon Fund publishes interest rate applicable to the bonds for the next interest period

Baltic Horizon Fund publishes interest rate applicable to the fund’s 5-year bonds (ISIN: EE3300003235) for the next 3-months interest period which starts on 8 February 2024. The annual interest rate applicable to the bonds for the interest period as referred above is 8% + 3.932% (EURIBOR 3-months) totaling 11.932% per annum. For additional information, please contact: Tarmo Karotam Baltic Horizon Fund manager E-mail tarmo.karotam@nh-cap.com www.baltichorizon.com Baltic Horizon Fund is a registered contractual public closed-end real estate fund managed by Alternative Investment Fund Manager license holder Northern Horizon Capital AS. Distribution: Nasdaq, GlobeNewswire, www.baltichorizon.com To receive Nasdaq announcements and news from Baltic Horizon Fund about its projects, plans and more, register on www.baltichorizon.com. You can also...

Continue reading

Baltic Horizon Fund publishes interest rate applicable to the bonds for the next interest period

Baltic Horizon Fund publishes interest rate applicable to the fund’s 5-year bonds (ISIN: EE3300003235) for the next 3-months interest period which starts on 8 February 2024. The annual interest rate applicable to the bonds for the interest period as referred above is 8% + 3.932% (EURIBOR 3-months) totaling 11.932% per annum. For additional information, please contact: Tarmo Karotam Baltic Horizon Fund manager E-mail tarmo.karotam@nh-cap.com www.baltichorizon.com Baltic Horizon Fund is a registered contractual public closed-end real estate fund managed by Alternative Investment Fund Manager license holder Northern Horizon Capital AS. Distribution: Nasdaq, GlobeNewswire, www.baltichorizon.com To receive Nasdaq announcements and news from Baltic Horizon Fund about its projects, plans and more, register on www.baltichorizon.com. You can also...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.